← Human Trials & Peer-Reviewed Studies

Effect of vitamin D supplementation on muscle energy phospho-metabolites: a ³¹P magnetic resonance spectroscopy-based pilot study.

Plain-language guide to PMID 24679100 (2014): pilot clinical trial of Vitamin D, K2, Magnesium and Zinc in 19 subjects.

Key Facts

PMID
24679100
Journal
Endocrine research
Year
2014
Study type
Clinical Trial
Authors
Rana P et al. (7 authors)
DOI
10.3109/07435800.2013.865210

What This Study Did, in Plain Language

What Was Tested

This clinical trial looks at Vitamin D, K2, Magnesium and Zinc.

The present study was proposed to investigate the influence of severe vitamin D deficiency on high-energy metabolite levels in resting skeletal muscle and thereafter, monitor the response after vitamin D supplementation using ³¹P magnetic resonance spectroscopy (MRS).

Why It Was Studied

There are several published reports on the prevalence of low vitamin D levels in otherwise healthy Indian population.

Study was conducted on 19 otherwise healthy subjects but with low serum 25(OH)D levels (<5 ng/ml).

Who Took Part

The abstract describes 19 subjects taking part.

By PubMed's age tags, the people studied were teenagers, young adults and adults, both men and women.

How the Study Was Run

The researchers set it up as a pilot study.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

What Was Measured

There are several published reports on the prevalence of low vitamin D levels in otherwise healthy Indian population.

Study was conducted on 19 otherwise healthy subjects but with low serum 25(OH)D levels (<5 ng/ml).

The subject headings attached to it are Adenosine Triphosphate, Calcifediol, Cholecalciferol, Dietary Supplements, Energy Metabolism, Hyperparathyroidism, Secondary and India.

The authors tagged it with the keywords MRS, oxidative phosphorylation, phosphocreatine and vitamin D deficiency.

What This Means in Plain Language

The paper is a pilot study of Vitamin D, K2, Magnesium and Zinc in 19 subjects.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2014 (Endocrine research), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.